Evidence map›Paper›PMID 24799116›Full record

ArticleEuropean journal of immunology2014

γδ T cells restrain extrathymic development of Foxp3+-inducible regulatory T cells via IFN-γ.

Anabelle Visperas, Bo Shen, Booki Min

Open access · greenAbstract read
In one paragraph

Article in European journal of immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Intestinal Regulatory T Cells.Advances in experimental medicine and biology · 2021
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anabelle VisperasDepartment of Immunology, Lerner Research Institute, Cleveland, OH, USA; Department of Molecular Medicine, Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Bo Shen
Booki Min
Case Western Reserve University · USCleveland Clinic · US

Funding

Homeostatic Regulation of T LymphocytesR01AI074932 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI MIN, BOOKI · 2009 to 2013
$1.9M
Molecular Medicine Training ProgramT32GM088088 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI SMITH, JONATHAN D · 2011 to 2020
$1.7M
NIAID NIH HHS R01 AI074932NIAID NIH HHS R01-AI074932NIGMS NIH HHS T32 GM088088NIGMS NIH HHS T32-GM88088
6 · The paper itself

Abstract

Inducible Treg (iTreg) cells generated from Ag-stimulated naïve CD4(+) T cells in the periphery play an important role in regulating immune responses. TGF-β is a key cytokine that promotes this conversion process; however, how this process is regulated in vivo remains unclear. Here, we report that γδ T cells play a crucial role in controlling iTreg generation and suppressor function. Ag-induced iTreg generation was significantly enhanced in C57BL/6 mice in the absence of γδ T cells. Inhibition of iTreg conversion was mediated by IFN-γ produced by activated γδ T cells but not by activated CD4(+) T cells. BM chimera experiments further confirmed γδ-derived IFN-γ-dependent mechanism in regulating iTreg generation in vivo. Lastly, human peripheral blood γδ T cells also interfere with iTreg conversion via IFN-γ. Our results suggest a novel function of γδ T cells in limiting the generation of iTreg cells, potentially balancing immunity and tolerance.

Indexed as

AnimalsForkhead Transcription FactorsHumansImmune ToleranceInterferon-gammaMiceMice, Inbred C57BLT-Lymphocytes, RegulatoryForkhead Transcription FactorsInterferon-gammaCD4+ T cellIFN-γInflammationIntestineiTreg cellsOral toleranceRegulatory T cellsγδ T cell

Identifiers

PMID24799116
PMCPMC4141022
OpenAlexW1583032319

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.